Forbes Nauzer, Cooray Mohan, Hackett Michael, Shah Nishwa, Yuan Yuhong, Antiperovitch Pavel, Corner Tracey, Chan David, Mills Michael, Armstrong David, Xenodemetropoulos Ted
Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
J Can Assoc Gastroenterol. 2020 Oct;3(5):204-209. doi: 10.1093/jcag/gwz013. Epub 2019 May 22.
The electronic clinical decision-making application was designed to assist physicians with evaluation of patients with suspected colorectal cancer (CRC). The physician completes an interactive checklist of evidence-based clinical parameters, and a recommended referral urgency is generated based on the post-test probability of CRC. This study aimed toward validation of the tool in symptomatic patients presenting with rectal bleeding.
The medical records of a sample of patients with histologically confirmed CRC from 2010 to 2014 were reviewed. The tool was applied retrospectively to all patients who initially presented with rectal bleeding, to determine its sensitivity for detecting CRC in this population. A generated recommendation of 'immediate referral' (referral ≤24 hours, expected endoscopy ≤2 weeks) or 'urgent referral' (expected consultation and endoscopy ≤4 and ≤8 weeks) was considered a positive test result. An a priori sensitivity of 90% was deemed adequate, based on test characteristics of the tool's individual clinical criteria.
The tool was applied to 281 patients. A total of 69 (24.6%) and 211 (75.1%) patients met criteria for immediate and urgent referral, respectively. The remaining patient (0.4%) met criteria for 'possible priority referral', while none met criteria for 'no specific action recommended'. This resulted in a calculated sensitivity of 99.6% (95% confidence interval 98.0 to 99.9%).
The tool is sensitive in the prediction of CRC in patients presenting with rectal bleeding. A prospective cohort study is being designed to allow for acquisition of comprehensive test performance characteristics and full validation of the instrument.
电子临床决策应用程序旨在协助医生评估疑似结直肠癌(CRC)患者。医生完成一份基于证据的临床参数交互式清单,然后根据CRC的检测后概率生成推荐的转诊紧急程度。本研究旨在验证该工具在出现直肠出血症状的患者中的有效性。
回顾了2010年至2014年组织学确诊为CRC的患者样本的病历。该工具被回顾性应用于所有最初表现为直肠出血的患者,以确定其在该人群中检测CRC的敏感性。生成的“立即转诊”(转诊≤24小时,预期内镜检查≤2周)或“紧急转诊”(预期会诊和内镜检查≤4周和≤8周)推荐被视为阳性检测结果。根据该工具各个临床标准的检测特征,先验敏感性90%被认为是足够的。
该工具应用于281例患者。分别有69例(24.6%)和211例(75.1%)患者符合立即转诊和紧急转诊标准。其余1例患者(0.4%)符合“可能优先转诊”标准,而无人符合“不建议采取特定行动”标准。这导致计算出的敏感性为99.6%(95%置信区间98.0至99.9%)。
该工具在预测出现直肠出血症状的患者的CRC方面具有敏感性。正在设计一项前瞻性队列研究,以获取全面的检测性能特征并对该仪器进行全面验证。